Flu vaccine study in kids aims to find best dosing strategy
NCT ID NCT06095947
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a quadrivalent influenza vaccine in 652 healthy children aged 3-8 years. Researchers compared immune responses after one dose versus two doses, and also checked for side effects. The goal was to find the best way to protect children against flu.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- quadrivalent influenza vaccine (split virion, inactivated)
- What this could lead to
- If successful, this could help determine the best dosing schedule for flu protection in young children.
- What could go wrong
- This is a completed study focused on immune response and safety, not on preventing actual flu illness. Results may not apply to other age groups or flu seasons.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GCP are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kou Zengqiang
Jinan, Shandong, 250000, China